by Bespoke Intel | Dec 27, 2023
If the second half of our year was to be defined by one topic, that topic would be GLP-1s. With the rise of drugs such as Ozempic and Wegovy, GLP-1 medications have been all the rage in the later half of 2023 due to their weight loss and impulse suppression effects....
by Bespoke Intel | Dec 27, 2023
If 2023 will be remembered in history for one thing, it would be the rise of generative AI into the main stream. The introduction of AI chatbots such as ChatGPT have changed the way that we interact with technology forever, and it doesn’t look like it’s...
by Bespoke Intel | Dec 27, 2023
Over the course of 2023, we’ve seen interest in Temu turn from a whisper to a roar. Since the beginning of the year, we’ve ran numerous surveys covering the Chinese ecommerce platform and have seen adoption rise dramatically. Although engagement has...
by Bespoke Intel | Dec 27, 2023
With federal student loan payments resuming back in October of this year, it’s been one of the most hot button issues over the course of 2023. Back in September before the payments resumed, we ran a large N survey on consumers to see how they would react to...
by Bespoke Intel | Dec 27, 2023
It would be putting it lightly to say that Carvana has been on quite a wild ride this year. In January, we published an article titled “Is Carvana Over? The Consumer Angle.” At the time the stock was trading at around $4.20 per share and there was serious concern that...
